GPT and cholestasis: To examine potential liver injury of AAV‐DNase I, markers of hepatocellular injury and cholestasis (ALT, AST, ALP, and total bilirubin) were evaluated at baseline and day 21 after AAV‐DNase I injection in wild‐type mice.